Literature DB >> 17026874

Eosinophilic disorders in children.

Amy Wagelie-Steffen1, Seema S Aceves.   

Abstract

Many pediatric diseases demonstrate blood or tissue eosinophilia. Included among these disorders are common atopic diatheses such as asthma as well as the rarer conditions of hypereosinophilic syndrome and eosinophilic gastrointestinal disorders. Eosinophil trafficking and activation in target organs leads to tissue damage and ongoing reparative attempts that can ultimately result in changes in organ structure and function. Recent treatment with biologic agents such as tyrosine kinase inhibitors and anti-interleukin-5 has offered new therapeutic options in certain eosinophilic disorders. Eosinophilic disorders such as eosinophilic esophagitis are increasingly being diagnosed in children, but many lessons in disease pathogenesis, diagnosis, optimal treatment, and natural history continue to be learned.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17026874     DOI: 10.1007/s11882-006-0024-5

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  49 in total

1.  Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response.

Authors:  A Straumann; M Bauer; B Fischer; K Blaser; H U Simon
Journal:  J Allergy Clin Immunol       Date:  2001-12       Impact factor: 10.793

2.  Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry.

Authors:  Jesus R Guajardo; Lauren M Plotnick; Jennifer M Fende; Margaret H Collins; Philip E Putnam; Marc E Rothenberg
Journal:  J Pediatr       Date:  2002-10       Impact factor: 4.406

Review 3.  The hypereosinophilic syndromes: still more heterogeneity.

Authors:  Gerald J Gleich; Kristin M Leiferman
Journal:  Curr Opin Immunol       Date:  2005-10-07       Impact factor: 7.486

4.  The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children.

Authors:  S R Orenstein; T M Shalaby; C Di Lorenzo; P E Putnam; L Sigurdsson; H Mousa; S A Kocoshis
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

5.  Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis.

Authors:  Steven J Steiner; Kevin M Kernek; Joseph F Fitzgerald
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-05       Impact factor: 2.839

6.  Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up.

Authors:  Mirna Chehade; Margret S Magid; Shideh Mofidi; Anna Nowak-Wegrzyn; Hugh A Sampson; Scott H Sicherer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-05       Impact factor: 2.839

7.  Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis.

Authors:  Sandeep K Gupta; Joseph F Fitzgerald; Tamara Kondratyuk; Harm HogenEsch
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-01       Impact factor: 2.839

8.  Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula.

Authors:  K J Kelly; A J Lazenby; P C Rowe; J H Yardley; J A Perman; H A Sampson
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

Review 9.  Eosinophilic gastrointestinal disorders (EGID).

Authors:  Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

10.  Blood and graft eosinophilia as predictors of rejection in human liver transplantation.

Authors:  P F Foster; H N Sankary; M Hart; M Ashmann; J W Williams
Journal:  Transplantation       Date:  1989-01       Impact factor: 4.939

View more
  2 in total

1.  Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation.

Authors:  Serge Alexander Sorser; Mohammed Barawi; Karen Hagglund; Mohammad Almojaned; Hernando Lyons
Journal:  J Gastroenterol       Date:  2012-05-23       Impact factor: 7.527

2.  Fasciola hepatica infection as a cause of severe hypereosinophilia.

Authors:  Meriç Kaymak Cihan; Cahit Babür; Lale Olcay
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.